Poolbeg Pharma (POLB) Ord Shares
0.30p
(10.34%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.30p
(10.34%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.30p
(10.34%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
2.90p
3.28p
13.90p
£22.31 million
2.90p
2.80p
2.40p
n/a
0.25p (9.43%) Previous:
0.25p
2,664,894
n/a
75,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Revenue (£m) | n/a | n/a |
| Profit before tax (£m) | (5.79) | (3.93) |
| Adjusted EPS (p): | (1.16) | (0.79) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Director dealings: Poolbeg Pharma co-founder raise stake
25 June 2025 14:46
-
Poolbeg Pharma extends cash runway after raising £4.87m
23 May 2025 12:40
-
Poolbeg raises nearly £5m to progress clinical trials
20 May 2025 11:27
-
Results of GM and AGM Meetings
23 June 2025 14:57
-
FDA Orphan Drug Designation granted for POLB 001
27 May 2025 07:01
-
Annual Report, AGM Notice & Circular
27 May 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.